On the basis of scientific breakthroughs in the past 30 years in the field of biotechnology, the number of patents has significantly increased, particularly in relation to genetic materials. Fernando Rincón looks at the Mexican situation.
Genetic material in the form of gene or partial DNA or RNA sequences plays an important role in medical research, for example, for the development of new drugs, tests and in diagnosis, monitoring and treatment of diseases as well as in agricultural and industrial fields.
In this regard, Article 16, Section II of the Industrial Property Law states:
“Inventions that are new, the result of an inventive step and susceptible of industrial application within the meaning of this Law shall be patentable, with the exception of: […] II. biological and genetic material as found in nature.”
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email tech support.
biotechnology, gene patents, Mexico